Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT01408576 · COMPLETED
Trial details
- NCT number
- NCT01408576
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2016-02-01
- Enrollment
- 1250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.